{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-26-000006","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2026-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.369265+00:00","generated_at":"2026-05-16T11:05:29.751645+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"GRI Bio increases ATM offering capacity to $7.38M, waives Dec 2025 SPA restrictions","bullets":["Increased ATM capacity by up to $7.38M in common stock; $6.17M already sold under the program.","Waived certain provisions of the Dec 11, 2025 securities purchase agreement to permit additional ATM issuances.","At-the-market offering agreement with H.C. Wainwright & Co. dated May 20, 2024 remains in effect."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-26-000006","json":"https://secwatch.observer/filing/0001824293-26-000006.json","markdown":"https://secwatch.observer/filing/0001824293-26-000006.md","text":"https://secwatch.observer/filing/0001824293-26-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429326000006/0001824293-26-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429326000006/val-20260109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:05:29.751645+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}